[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Plasma Protein Therapeutics Market Research Report 2017

January 2017 | 123 pages | ID: C44A87BB808EN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Plasma Protein Therapeutics

Revenue, means the sales value of Plasma Protein Therapeutics

This report studies Plasma Protein Therapeutics in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
  • Baxter International
  • Biotest
  • CSL Behring
  • Grifols, S.A.
  • Kedrion
  • Octapharma USA
  • Shire Plc
  • China Biologics
  • Kamada
Market Segment by Regions (provinces), covering
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • C1 esterase Inhibitors
  • Albumins
  • Immunoglobulins
  • Coagulation Factors
  • Others
Split by Application, this report focuses on consumption, market share and growth rate of Plasma Protein Therapeutics in each application, can be divided into
  • Hereditary Angioedema
  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Secondary Immunodeficiency
  • Idiopathic Thrombocytopenic
  • Others (Kawasaki disease, GBS, CIDP etc)
China Plasma Protein Therapeutics Market Research Report 2017

1 PLASMA PROTEIN THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Plasma Protein Therapeutics Segment by Type
  1.2.1 China Production Market Share of Plasma Protein Therapeutics Type in 2015
  1.2.2 C1 esterase Inhibitors
  1.2.3 Albumins
  1.2.4 Immunoglobulins
  1.2.5 Coagulation Factors
  1.2.6 Others
1.3 Applications of Plasma Protein Therapeutics
  1.3.1 Plasma Protein Therapeutics Consumption Market Share by Application in 2015
  1.3.2 Hereditary Angioedema
  1.3.3 Hemophilia
  1.3.4 Primary Immunodeficiency Disorder
  1.3.5 Secondary Immunodeficiency
  1.3.6 Idiopathic Thrombocytopenic
  1.3.7 Others (Kawasaki disease, GBS, CIDP etc)
1.4 China Market Size (Value) of Plasma Protein Therapeutics (2011-2021)
1.5 China Plasma Protein Therapeutics Status and Outlook
1.6 Government Policies

2 CHINA PLASMA PROTEIN THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 China Plasma Protein Therapeutics Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Plasma Protein Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Plasma Protein Therapeutics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Plasma Protein Therapeutics Market Competitive Situation and Trends
  2.5.1 Plasma Protein Therapeutics Market Concentration Rate
  2.5.2 Plasma Protein Therapeutics Market Share of Top 3 and Top 5 Manufacturers

3 CHINA PLASMA PROTEIN THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

3.1 Baxter International
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.1.2.1 C1 esterase Inhibitors
    3.1.2.2 Albumins
  3.1.3 Baxter International Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Biotest
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.2.2.1 C1 esterase Inhibitors
    3.2.2.2 Albumins
  3.2.3 Biotest 123 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 CSL Behring
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.3.2.1 C1 esterase Inhibitors
    3.3.2.2 Albumins
  3.3.3 CSL Behring 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Grifols, S.A.
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.4.2.1 C1 esterase Inhibitors
    3.4.2.2 Albumins
  3.4.3 Grifols, S.A. Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Kedrion
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.5.2.1 C1 esterase Inhibitors
    3.5.2.2 Albumins
  3.5.3 Kedrion Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Octapharma USA
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.6.2.1 C1 esterase Inhibitors
    3.6.2.2 Albumins
  3.6.3 Octapharma USA Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Shire Plc
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.7.2.1 C1 esterase Inhibitors
    3.7.2.2 Albumins
  3.7.3 Shire Plc Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 China Biologics
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.8.2.1 C1 esterase Inhibitors
    3.8.2.2 Albumins
  3.8.3 China Biologics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Kamada
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Plasma Protein Therapeutics Product Type, Application and Specification
    3.9.2.1 C1 esterase Inhibitors
    3.9.2.2 Albumins
  3.9.3 Kamada Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview

4 CHINA PLASMA PROTEIN THERAPEUTICS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Plasma Protein Therapeutics Capacity, Production and Growth (2011-2016)
4.2 China Plasma Protein Therapeutics Revenue and Growth (2011-2016)
4.3 China Plasma Protein Therapeutics Production, Consumption, Export and Import (2011-2016)

5 CHINA PLASMA PROTEIN THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Plasma Protein Therapeutics Production and Market Share by Type (2011-2016)
5.2 China Plasma Protein Therapeutics Revenue and Market Share by Type (2011-2016)
5.3 China Plasma Protein Therapeutics Price by Type (2011-2016)
5.4 China Plasma Protein Therapeutics Production Growth by Type (2011-2016)

6 CHINA PLASMA PROTEIN THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 China Plasma Protein Therapeutics Consumption and Market Share by Application (2011-2016)
6.2 China Plasma Protein Therapeutics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINAPLASMA PROTEIN THERAPEUTICS MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Plasma Protein Therapeutics Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Plasma Protein Therapeutics Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Plasma Protein Therapeutics Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Plasma Protein Therapeutics Sales Price by Regions (Provinces)(2011-2016)
7.2 China Plasma Protein Therapeutics Consumption by Regions (Provinces)(2011-2016)
7.3 China Plasma Protein Therapeutics Production, Consumption, Export and Import (2011-2016)

8 PLASMA PROTEIN THERAPEUTICS MANUFACTURING COST ANALYSIS

8.1 Plasma Protein Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Plasma Protein Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA PLASMA PROTEIN THERAPEUTICS MARKET FORECAST (2016-2021)

12.1 China Plasma Protein Therapeutics Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Plasma Protein Therapeutics Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Plasma Protein Therapeutics Production Forecast by Type (2016-2021)
12.4 China Plasma Protein Therapeutics Consumption Forecast by Application (2016-2021)
12.5 China Plasma Protein Therapeutics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Plasma Protein Therapeutics Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Plasma Protein Therapeutics Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Plasma Protein Therapeutics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Plasma Protein Therapeutics Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Plasma Protein Therapeutics
Figure China Production Market Share of Plasma Protein Therapeutics by Type in 2015
Figure Product Picture of C1 esterase Inhibitors
Table Major Manufacturers of C1 esterase Inhibitors
Figure Product Picture of Albumins
Table Major Manufacturers of Albumins
Figure Product Picture of Immunoglobulins
Table Major Manufacturers of Immunoglobulins
Figure Product Picture of Coagulation Factors
Table Major Manufacturers of Coagulation Factors
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Plasma Protein Therapeutics Consumption Market Share by Application in 2015
Figure Hereditary Angioedema Examples
Figure Hemophilia Examples
Figure Primary Immunodeficiency Disorder Examples
Figure Secondary Immunodeficiency Examples
Figure Idiopathic Thrombocytopenic Examples
Figure Others (Kawasaki disease, GBS, CIDP etc) Examples
Figure China Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Table China Plasma Protein Therapeutics Capacity of Key Manufacturers (2015 and 2016)
Table China Plasma Protein Therapeutics Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Plasma Protein Therapeutics Capacity of Key Manufacturers in 2015
Figure China Plasma Protein Therapeutics Capacity of Key Manufacturers in 2016
Table China Plasma Protein Therapeutics Production of Key Manufacturers (2015 and 2016)
Table China Plasma Protein Therapeutics Production Share by Manufacturers (2015 and 2016)
Figure 2015 Plasma Protein Therapeutics Production Share by Manufacturers
Figure 2016 Plasma Protein Therapeutics Production Share by Manufacturers
Table China Plasma Protein Therapeutics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Plasma Protein Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Plasma Protein Therapeutics Revenue Share by Manufacturers
Table 2016 China Plasma Protein Therapeutics Revenue Share by Manufacturers
Table China Market Plasma Protein Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Plasma Protein Therapeutics Average Price of Key Manufacturers in 2015
Table Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Plasma Protein Therapeutics Product Type
Figure Plasma Protein Therapeutics Market Share of Top 3 Manufacturers
Figure Plasma Protein Therapeutics Market Share of Top 5 Manufacturers
Table Baxter International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter International Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter International Plasma Protein Therapeutics Market Share (2011-2016)
Table Biotest Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotest Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biotest Plasma Protein Therapeutics Market Share (2011-2016)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Behring Plasma Protein Therapeutics Market Share (2011-2016)
Table Grifols, S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols, S.A. Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Grifols, S.A. Plasma Protein Therapeutics Market Share (2011-2016)
Table Kedrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kedrion Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Kedrion Plasma Protein Therapeutics Market Share (2011-2016)
Table Octapharma USA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Octapharma USA Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Octapharma USA Plasma Protein Therapeutics Market Share (2011-2016)
Table Shire Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Plc Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Shire Plc Plasma Protein Therapeutics Market Share (2011-2016)
Table China Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China Biologics Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure China Biologics Plasma Protein Therapeutics Market Share (2011-2016)
Table Kamada Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kamada Plasma Protein Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Kamada Plasma Protein Therapeutics Market Share (2011-2016)
Figure China Plasma Protein Therapeutics Capacity, Production and Growth (2011-2016)
Figure China Plasma Protein Therapeutics Revenue (Million USD) and Growth (2011-2016)
Table China Plasma Protein Therapeutics Production, Consumption, Export and Import (2011-2016)
Table China Plasma Protein Therapeutics Production by Type (2011-2016)
Table China Plasma Protein Therapeutics Production Share by Type (2011-2016)
Figure Production Market Share of Plasma Protein Therapeutics by Type (2011-2016)
Figure 2015 Production Market Share of Plasma Protein Therapeutics by Type
Table China Plasma Protein Therapeutics Revenue by Type (2011-2016)
Table China Plasma Protein Therapeutics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Plasma Protein Therapeutics by Type (2011-2016)
Figure 2015 Revenue Market Share of Plasma Protein Therapeutics by Type
Table China Plasma Protein Therapeutics Price by Type (2011-2016)
Figure China Plasma Protein Therapeutics Production Growth by Type (2011-2016)
Table China Plasma Protein Therapeutics Consumption by Application (2011-2016)
Table China Plasma Protein Therapeutics Consumption Market Share by Application (2011-2016)
Figure China Plasma Protein Therapeutics Consumption Market Share by Application in 2015
Table China Plasma Protein Therapeutics Consumption Growth Rate by Application (2011-2016)
Figure China Plasma Protein Therapeutics Consumption Growth Rate by Application (2011-2016)
Table China Plasma Protein Therapeutics Production by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Production Market Share by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Production Value by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Sales Price by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Consumption by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Plasma Protein Therapeutics Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protein Therapeutics
Figure Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure Plasma Protein Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
Table Major Buyers of Plasma Protein Therapeutics
Table Distributors/Traders List
Figure China Plasma Protein Therapeutics Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table China Plasma Protein Therapeutics Production, Import, Export and Consumption Forecast (2016-2021)
Table China Plasma Protein Therapeutics Production Forecast by Type (2016-2021)
Table China Plasma Protein Therapeutics Consumption Forecast by Application (2016-2021)
Table China Plasma Protein Therapeutics Production Forecast by Regions (Provinces)(2016-2021)
Table China Plasma Protein Therapeutics Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Plasma Protein Therapeutics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)


More Publications